CVS HEALTH Corp
In its 13F for Q4 2025 (holdings as of December 31, 2025, filed February 13, 2026), CVS HEALTH Corp reported 9 stock positions worth $135.3 million. Its top holding was SS SPDR S&P 500 ETF Trust-US (SPY) at 77.6% of the portfolio, followed by iShares Broad Usd High Yield (USHY, 7.4%) and iShares 5-10Y Inv Grade (IGIB, 3.7%). Compared with Q3 2025, it opened 6 new positions. The biggest buy was a new position in iShares Broad Usd High Yield (USHY).
- Most Recent 13F
- Q2 2026
- Location
- WOONSOCKET, RI
- CIK
- 0000064803
- Portfolio Value
- $135.3M (Q4 2025)
- SEC Filing
- 0001193125-26-051367 ↗ filed Feb 13, 2026
Holdings Value
Holdings 9 stocks · $135.3M
| SPY SS SPDR S&P 500 ETF Trust-US | 77.55% | 153,891 | $104.9M | No change |
| USHY iShares Broad Usd High Yield | 7.41% | 268,100 | $10.0M | New |
| IGIB iShares 5-10Y Inv Grade Corp. | 3.69% | 92,750 | $5.0M | New |
| JAAA Janus Henderson Aaa Clo ETF | 3.69% | 98,795 | $5.0M | New |
| IGSB iShares 1-5Y Inv Grade Corp. | 3.69% | 94,400 | $5.0M | New |
| JPST JPMorgan Ultra-Short Income | 3.68% | 98,500 | $5.0M | New |
| PRU Prudential Financial Inc. | 0.22% | 2,683 | $303K | No change |
| HCAT Health Catalyst Inc. | 0.06% | 32,273 | $77K | No change |
| NEAR iShares SH Dba ETF Usd Inc. | 0.00% | 6 | $307 | New |
Portfolio Sells Q3 2025 → Q4 2025
| None this quarter. | |||
Portfolio Buys Q3 2025 → Q4 2025
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 21 | $225.2M | IGSB, IGIB, IEI, SHY, USHY |
| Q1 2026 | 33 | $212.3M | SPY, IEI, SHY, IGSB, AGG |
| Q4 2025 | 9 | $135.3M | SPY, USHY, IGIB, JAAA, IGSB |
| Q3 2025 | 3 | $102.9M | SPY, PRU, HCAT |
| Q2 2025 | 3 | $190.6M | SPY, PRU, HCAT |
| Q1 2025 | 3 | $172.7M | SPY, PRU, HCAT |
| Q4 2024 | 3 | $233.7M | SPY, PRU, HCAT |
| Q3 2024 | 5 | $230.2M | SPY, VYM, HDV, PRU, HCAT |
| Q2 2024 | 5 | $216.8M | SPY, VYM, HDV, PRU, HCAT |
| Q1 2024 | 5 | $211.7M | SPY, VYM, HDV, PRU, HCAT |